Clinical Trials List
2024-12-01 - 2028-12-31
Phase I/II
Recruiting5
ICD-10C67.9
Malignant neoplasm of bladder, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9188.9
Malignant neoplasm of bladder, part unspecified
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Ching-Chia Li 無
- Sheng-Chen Wen 無
- Hsiang Ying Lee 無
- 張顥瀚 無
- 阮雍順 無
- Tsu-Ming Chien 無
- 盧嘉文 無
- Hung-Lung Ke 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王樹吉 無
- 洪晟鈞 無
- 梅承恩 無
- 楊涵中 無
- Shian-Shiang Wang 無
- Chia-Yen Lin 無
- 張瓈文 無
- Cheng-Kuang Yang 無
- Jian-Ri Li 無
- JU-CHUAN HU 無
- 裘坤元 無
- 林雁婷 無
- 張家程 無
- Chuan-Shu Chen 無
- 賴谷順 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
290 participants
